HEADER VIRAL PROTEIN 10-SEP-12 2LY0 TITLE SOLUTION NMR STRUCTURE OF THE INFLUENZA A VIRUS S31N MUTANT (19-49) IN TITLE 2 PRESENCE OF DRUG M2WJ332 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MEMBRANE ION CHANNEL M2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 4 ORGANISM_TAXID: 221020 KEYWDS INFLUENZA A VIRUS, M2 CHANNEL, S31N INHIBITOR, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.WU,J.WANG,W.DEGRADO REVDAT 4 14-JUN-23 2LY0 1 REMARK REVDAT 3 06-FEB-13 2LY0 1 JRNL REVDAT 2 23-JAN-13 2LY0 1 JRNL REVDAT 1 09-JAN-13 2LY0 0 JRNL AUTH J.WANG,Y.WU,C.MA,G.FIORIN,J.WANG,L.H.PINTO,R.A.LAMB, JRNL AUTH 2 M.L.KLEIN,W.F.DEGRADO JRNL TITL STRUCTURE AND INHIBITION OF THE DRUG-RESISTANT S31N MUTANT JRNL TITL 2 OF THE M2 ION CHANNEL OF INFLUENZA A VIRUS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 110 1315 2013 JRNL REFN ISSN 0027-8424 JRNL PMID 23302696 JRNL DOI 10.1073/PNAS.1216526110 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE, X-PLOR NIH REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRPIPE), SCHWIETERS, KUSZEWSKI, TJANDRA AND REMARK 3 CLORE (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LY0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000102973. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 0.05 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM MM [U-100% 15N] PROTEIN, REMARK 210 90% H2O/10% D2O; 2 MM MM [U-100% REMARK 210 13C; U-100% 15N] PROTEIN, 90% REMARK 210 H2O/10% D2O; 2 MM MM [U-100% 13C; REMARK 210 U-100% 15N; U-80% 2H] PROTEIN, REMARK 210 90% H2O/10% D2O; 2 MM MM [U-10% REMARK 210 13C; U-100% 15N] PROTEIN, 90% REMARK 210 H2O/10% D2O; 2MM MM MIXATURE OF REMARK 210 50% 13C15N AND 50% 12C14N REMARK 210 PROTEIN, 90% H2O/10% D2O; 2MM MM REMARK 210 13C15N OF V27A30N31I33G34 REMARK 210 PROTEIN, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCO; 3D REMARK 210 HNCA; 3D HNCACB; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY; 2D 1H-13C HSQC; REMARK 210 3D CCH_TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY, X-PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 48 162.29 -45.14 REMARK 500 1 PHE B 48 162.38 -45.19 REMARK 500 1 PHE C 48 162.34 -45.20 REMARK 500 1 PHE D 48 162.37 -45.29 REMARK 500 5 PHE A 47 40.62 -93.64 REMARK 500 5 PHE A 48 173.82 -45.84 REMARK 500 5 PHE B 47 40.69 -93.61 REMARK 500 5 PHE B 48 173.82 -45.85 REMARK 500 5 PHE C 47 40.62 -93.54 REMARK 500 5 PHE C 48 173.81 -46.01 REMARK 500 5 PHE D 47 40.68 -93.55 REMARK 500 5 PHE D 48 173.93 -46.06 REMARK 500 6 PHE A 47 40.50 -92.56 REMARK 500 6 PHE B 47 40.55 -92.58 REMARK 500 6 PHE C 47 40.67 -92.59 REMARK 500 6 PHE D 47 40.68 -92.72 REMARK 500 7 PHE A 48 66.02 -155.58 REMARK 500 7 PHE B 48 66.46 -155.69 REMARK 500 7 PHE C 48 66.42 -155.63 REMARK 500 7 PHE D 48 66.54 -155.52 REMARK 500 8 SER A 23 -143.80 -149.12 REMARK 500 8 SER B 23 -143.76 -149.28 REMARK 500 8 SER C 23 -143.79 -149.18 REMARK 500 8 SER D 23 -143.75 -149.20 REMARK 500 9 PHE A 47 40.71 -101.26 REMARK 500 9 PHE A 48 86.47 -45.71 REMARK 500 9 PHE B 47 40.81 -101.02 REMARK 500 9 PHE B 48 86.58 -45.83 REMARK 500 9 PHE C 47 40.88 -101.45 REMARK 500 9 PHE C 48 86.21 -45.81 REMARK 500 9 PHE D 47 40.79 -101.27 REMARK 500 9 PHE D 48 86.47 -45.92 REMARK 500 11 ASP A 24 151.59 -49.42 REMARK 500 11 ASP B 24 151.25 -49.40 REMARK 500 11 ASP C 24 151.47 -49.30 REMARK 500 11 ASP D 24 151.04 -49.79 REMARK 500 13 PHE A 47 -72.41 -68.90 REMARK 500 13 PHE B 47 -72.52 -68.72 REMARK 500 13 PHE C 47 -72.45 -68.89 REMARK 500 13 PHE D 47 -72.44 -68.82 REMARK 500 15 SER A 23 -136.41 -75.89 REMARK 500 15 PHE A 48 83.55 -155.16 REMARK 500 15 SER B 23 -136.46 -76.00 REMARK 500 15 PHE B 48 83.54 -155.09 REMARK 500 15 SER C 23 -136.54 -75.81 REMARK 500 15 PHE C 48 83.51 -155.10 REMARK 500 15 SER D 23 -136.39 -75.86 REMARK 500 15 PHE D 48 83.69 -155.06 REMARK 500 18 PHE A 48 70.71 -156.90 REMARK 500 18 PHE B 48 70.92 -156.89 REMARK 500 REMARK 500 THIS ENTRY HAS 56 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A2Y A 100 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18706 RELATED DB: BMRB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THIS IS A DRUG-RESISTANT MUTANT. DBREF 2LY0 A 19 49 UNP Q6XT21 Q6XT21_9INFA 19 49 DBREF 2LY0 B 19 49 UNP Q6XT21 Q6XT21_9INFA 19 49 DBREF 2LY0 C 19 49 UNP Q6XT21 Q6XT21_9INFA 19 49 DBREF 2LY0 D 19 49 UNP Q6XT21 Q6XT21_9INFA 19 49 SEQADV 2LY0 SER A 19 UNP Q6XT21 CYS 19 SEE REMARK 999 SEQADV 2LY0 SER B 19 UNP Q6XT21 CYS 19 SEE REMARK 999 SEQADV 2LY0 SER C 19 UNP Q6XT21 CYS 19 SEE REMARK 999 SEQADV 2LY0 SER D 19 UNP Q6XT21 CYS 19 SEE REMARK 999 SEQRES 1 A 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 A 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 A 31 ARG LEU PHE PHE LYS SEQRES 1 B 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 B 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 B 31 ARG LEU PHE PHE LYS SEQRES 1 C 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 C 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 C 31 ARG LEU PHE PHE LYS SEQRES 1 D 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 D 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 D 31 ARG LEU PHE PHE LYS HET A2Y A 100 45 HETNAM A2Y (3S,5S,7S)-N-{[5-(THIOPHEN-2-YL)-1,2-OXAZOL-3- HETNAM 2 A2Y YL]METHYL}TRICYCLO[3.3.1.1~3,7~]DECAN-1-AMINIUM FORMUL 5 A2Y C18 H23 N2 O S 1+ HELIX 1 1 ASP A 24 PHE A 47 1 24 HELIX 2 2 ASP B 24 PHE B 47 1 24 HELIX 3 3 ASP C 24 PHE C 47 1 24 HELIX 4 4 ASP D 24 PHE D 47 1 24 SITE 1 AC1 5 VAL A 27 ALA A 30 VAL B 27 VAL C 27 SITE 2 AC1 5 VAL D 27 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1